Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Nature Reviews. Immunology|July 24, 2010
Prostate cancer as a model for tumour immunotherapyCharles G Drake
The Urologic Clinics of North America|February 16, 2010
Immunotherapy for prostate cancer: an emerging treatment modalityCharles G Drake
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Immunotherapy for prostate cancer: walk, don't runCharles G Drake
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Update on prostate cancer vaccinesCharles G Drake
Urologic Oncology|September 12, 2006
Basic overview of current immunotherapy approaches in urologic malignancyCharles G Drake
Urologic Oncology|July 3, 2008
Immunotherapy for metastatic prostate cancerCharles G Drake
Oncology (Williston Park, N.Y.)|November 19, 2014
Visceral metastases and prostate cancer treatment: 'die hard,' 'tough neighborhoods,' or 'evil humors'?Charles G Drake
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2021
Myeloid Resistance is not Futile: Biomarkers of Immunotherapy in Bladder CancerCharles G Drake
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Risk Associated With High-Dose BicalutamideCharles G Drake
Blood|December 11, 2012
Gone baby gone - but how?Charles G Drake
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Nature Reviews. Immunology|July 24, 2010
Prostate cancer as a model for tumour immunotherapyCharles G Drake
The Urologic Clinics of North America|February 16, 2010
Immunotherapy for prostate cancer: an emerging treatment modalityCharles G Drake
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Immunotherapy for prostate cancer: walk, don't runCharles G Drake
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Update on prostate cancer vaccinesCharles G Drake
Urologic Oncology|September 12, 2006
Basic overview of current immunotherapy approaches in urologic malignancyCharles G Drake
Urologic Oncology|July 3, 2008
Immunotherapy for metastatic prostate cancerCharles G Drake
Oncology (Williston Park, N.Y.)|November 19, 2014
Visceral metastases and prostate cancer treatment: 'die hard,' 'tough neighborhoods,' or 'evil humors'?Charles G Drake
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2021
Myeloid Resistance is not Futile: Biomarkers of Immunotherapy in Bladder CancerCharles G Drake
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Risk Associated With High-Dose BicalutamideCharles G Drake
Blood|December 11, 2012
Gone baby gone - but how?Charles G Drake
Pageof 27